Recce Pharmaceuticals Ltd (RCE.AX)
AUD 0.45
(-3.23%)
AUD 0.45
(-3.23%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 6.36 Million AUD | 149.22% |
| 2023 | 2.55 Million AUD | -79.75% |
| 2022 | 12.62 Million AUD | -41.78% |
| 2021 | 21.68 Million AUD | 568.34% |
| 2020 | 3.24 Million AUD | 251.79% |
| 2019 | 922.18 Thousand AUD | -19.37% |
| 2018 | 1.14 Million AUD | -21.91% |
| 2017 | 1.46 Million AUD | -60.64% |
| 2016 | 3.72 Million AUD | -25.39% |
| 2015 | 4.98 Million AUD | 3267.67% |
| 2014 | 148.07 Thousand AUD | 85.95% |
| 2013 | 79.63 Thousand AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 6.36 Million AUD | 0.0% |
| 2024 FY | 6.36 Million AUD | 149.22% |
| 2024 Q2 | 5.47 Million AUD | 0.0% |
| 2023 Q4 | 2.55 Million AUD | 0.0% |
| 2023 FY | 2.55 Million AUD | -79.75% |
| 2023 Q2 | 2.63 Million AUD | 0.0% |
| 2022 Q2 | 16.76 Million AUD | 0.0% |
| 2022 FY | 12.62 Million AUD | -41.78% |
| 2022 Q4 | 12.62 Million AUD | 0.0% |
| 2021 Q4 | 21.68 Million AUD | 0.0% |
| 2021 FY | 21.68 Million AUD | 568.34% |
| 2021 Q2 | 24.72 Million AUD | 0.0% |
| 2020 Q4 | 3.24 Million AUD | 0.0% |
| 2020 FY | 3.24 Million AUD | 251.79% |
| 2020 Q2 | 5.41 Million AUD | 0.0% |
| 2019 Q2 | 571.5 Thousand AUD | 0.0% |
| 2019 FY | 922.18 Thousand AUD | -19.37% |
| 2019 Q4 | 922.18 Thousand AUD | 0.0% |
| 2018 Q4 | 1.14 Million AUD | 0.0% |
| 2018 FY | 1.14 Million AUD | -21.91% |
| 2018 Q2 | 1.69 Million AUD | 0.0% |
| 2017 FY | 1.46 Million AUD | -60.64% |
| 2017 Q4 | 1.46 Million AUD | 0.0% |
| 2017 Q2 | 2.47 Million AUD | 0.0% |
| 2016 Q4 | 3.72 Million AUD | 0.0% |
| 2016 Q2 | 5.07 Million AUD | 0.0% |
| 2016 FY | 3.72 Million AUD | -25.39% |
| 2015 Q4 | 546.43 Thousand AUD | 0.0% |
| 2015 FY | 4.98 Million AUD | 3267.67% |
| 2015 Q3 | 546.43 Thousand AUD | 0.0% |
| 2014 FY | 148.07 Thousand AUD | 85.95% |
| 2013 FY | 79.63 Thousand AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 25.55 Million AUD | 75.072% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -281.09% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -22.884% |
| Biome Australia Limited | 8.27 Million AUD | 23.042% |
| Patrys Limited | 4.16 Million AUD | -53.058% |
| Orthocell Limited | 26.61 Million AUD | 76.068% |
| Imugene Limited | 151.39 Million AUD | 95.793% |
| Noxopharm Limited | 6.78 Million AUD | 6.105% |
| PYC Therapeutics Limited | 91.23 Million AUD | 93.019% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | 58.295% |
| Prescient Therapeutics Limited | 20.39 Million AUD | 68.765% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | 41.429% |
| Cynata Therapeutics Limited | 8.38 Million AUD | 24.065% |
| CSL Limited | 56.93 Billion AUD | 99.989% |
| Arovella Therapeutics Limited | 13.28 Million AUD | 52.053% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -101.596% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 97.244% |
| Starpharma Holdings Limited | 36.81 Million AUD | 82.698% |
| Nanollose Limited | 241.95 Thousand AUD | -2532.605% |
| Memphasys Limited | 12.43 Million AUD | 48.757% |
| Invex Therapeutics Ltd | 6.12 Million AUD | -4.078% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -17.177% |
| Amplia Therapeutics Limited | 14.84 Million AUD | 57.093% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | 94.336% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -148.379% |
| Race Oncology Limited | 20.22 Million AUD | 68.512% |
| Nyrada Inc. | 5.9 Million AUD | -7.827% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 98.401% |
| Dimerix Limited | 32.07 Million AUD | 80.144% |
| PharmAust Limited | 11.12 Million AUD | 42.744% |
| Immutep Limited | 147.44 Million AUD | 95.68% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 95.881% |
| Alterity Therapeutics Limited | 19.22 Million AUD | 66.866% |
| BTC Health Limited | 5.14 Million AUD | -23.71% |
| Acrux Limited | 8.96 Million AUD | 28.934% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 97.431% |
| Biotron Limited | 493.47 Thousand AUD | -1190.765% |
| Tissue Repair Ltd | 19.38 Million AUD | 67.149% |
| AdAlta Limited | 5.57 Million AUD | -14.294% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | 91.158% |
| Hexima Limited | 2.26 Million AUD | -180.723% |
| AnteoTech Limited | 9.38 Million AUD | 32.102% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 76.745% |
| Avecho Biotechnology Limited | 7.31 Million AUD | 12.975% |
| Actinogen Medical Limited | 21.31 Million AUD | 70.112% |
| Immuron Limited | 15.54 Million AUD | 59.038% |
| Argenica Therapeutics Limited | 16.37 Million AUD | 61.108% |